Long-Term Outcomes of S-1 Combined With Low-Dose Docetaxel as Neoadjuvant Chemotherapy (N-1 Study, Phase II Trial) in Patients With Operable Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-Term Outcomes of S-1 Combined With Low-Dose Docetaxel as Neoadjuvant Chemotherapy (N-1 Study, Phase II Trial) in Patients With Operable Breast Cancer

Published:2024-07 Issue:5 Volume:24 Page:e350-e359.e2
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Sasa Soichiro,Inoue Hiroaki,Nakagawa Misako,Toba Hiroaki,Goto Masakazu,Okumura Kazumasa,Misaki Mariko,Inui Tomohiro,Yukishige Sawaka,Nishisho Aya,Hino Naoki,Kanematsu Miyuki,Bando Yoshimi,Uehara Hisanori,Tangoku Akira,Takizawa Hiromitsu

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Reference34 articles.

1. Pathological complete response and long-term clinical benefit in breast cancer: The CTNeoBC pooled analysis;Cortazar;Lancet,2014

2. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes;von Minckwitz;J Clin Oncol,2012

3. Prognostic significance of subtype and pathologic response in operable breast cancer; a pooled analysis of prospective neoadjuvant studies of JBCRG;Kuroi;Breast Cancer,2015

4. Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy;Houssami;Eur J Cancer,2012

5. Cardiotoxicity of anticancer treatments;Ewer;Nat Rev Cardiol,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP